Abstract
TI-201 has been used mainly as a myocardial perfusion agent. Its use as a tumor agent was first described in 1976, and many types of malignancies have been detected with TI-201. However, scintigraphic detection of esophageal cancer by TI-201 has rarely been reported.
Original language | English |
---|---|
Pages (from-to) | 77 |
Number of pages | 1 |
Journal | Clinical Nuclear Medicine |
Volume | 28 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2003 |
Externally published | Yes |
Keywords
- Esophageal Cancer
- TI-201 Chest SPECT
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging